Clinical Trials on EGFR Mutated EGFR TKI Naive Metastatic NSCLC in China
Total 56 results
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
Sun Yat-sen UniversityRecruitingNon-small Cell Lung Cancer (NSCLC) | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation | Somatic Mutation | Germline MutationsChina
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Shenzhen People's HospitalUnknown
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Metastatic Lung Cancer | Antineoplastic Agents | Brain Metastases | Lung Neoplasm Malignant | EGFR... and other conditionsUnited States, Canada, Korea, Republic of, Japan, Taiwan
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC PatientsKorea, Republic of, Russian Federation, Malaysia, China, Australia, Taiwan, Thailand, Indonesia, Singapore
-
Sichuan Provincial People's HospitalUnknownStage IV EGFR Mutated NSCL With Brain MetastasesChina
-
Henan Cancer HospitalUnknownAdvanced NSCLC With EGFR MutationChina
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central... and other collaboratorsRecruitingLung Cancer, Non-small Cell | Circulating Tumor DNA | EGFR Gene Mutation | EGFR-TKI Resistant Mutation | Primary ResistanceChina
-
Second Affiliated Hospital of Nanchang UniversityJiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingNSCLC | EGFR Activating Mutation | Leptomeningeal MetastasisChina
-
Peking Union Medical CollegeRecruitingNSCLC | Brain Metastases | Furmonertinib | EGFR-mutationChina
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Peking Union Medical CollegeRecruitingNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, RecurrentChina
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
Fudan UniversityCompletedNSCLC Stage IV | EGFR Activating MutationChina
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRTChina
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Baodong QinUnknownNSCLC Stage IV | Anlotinib | EGFR T790M-negative | JS001China
-
TYK Medicines, IncRecruitingNSCLC | Brain Metastases | EGFR Activating MutationChina
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
TYK Medicines, IncActive, not recruitingNSCLC | Brain Metastases | EGFR Activating Mutation | Leptomeningeal MetastasisChina
-
Sichuan Provincial People's HospitalTerminatedStage IV EGFR Mutated Non-Small Cell Lung CancerChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNSCLC | EGFR Gene MutationChina
-
Qingdao Central HospitalCompletedEGFR-TKI Resistant MutationChina
-
InventisBio Co., LtdCompletedNSCLC | Solid Tumor | EGFR T790MChina
-
The Fourth Affiliated Hospital of Zhejiang University...CompletedNSCLC | EGFR Gene Mutation | Non-small-lung-cell CancerChina
-
Fudan UniversityRecruitingCarcinosarcoma | Sarcomatoid Carcinoma | PD-1 Immunotherapy | VEGFR-TKIChina
-
TYK Medicines, IncRecruitingNSCLC | EGFR Activating MutationChina
-
Hangzhou Cancer HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)China
-
Tongji UniversityRecruitingA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNSCLC, Stage IIIA | EGF-R Negative Non-Small Cell Lung Cancer | ALK Negative NSCLCChina
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung Cancer | Aquired Resistance | EGFR TKIsChina
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | Stage III NSCLCChina
-
Sun Yat-sen UniversityRecruitingBrain Metastases | Radiotherapy | EGFR Activating MutationChina
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
Sichuan UniversityAstraZenecaTerminatedNon-small Cell Lung Cancer Metastatic | EGFR Activating MutationChina
-
Shanghai Chest HospitalRecruitingMetastatic Cancer | Adenocarcinoma of Lung | Non-Small Cell Lung Cancer With EGFR Mutation | Locally Advanced Solid TumorChina
-
Allist Pharmaceuticals, Inc.UnknownLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung CancerChina
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion MutationsChina
-
Tongji UniversityRecruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal MetastasisChina
-
First People's Hospital of HangzhouUnknownNon-small Cell Lung Cancer Stage III | Adenocarcinoma of Lung | Non-Small-Cell Lung Cancer Metastatic | EGFR WildtypeChina
-
Alpha Biopharma (Jiangsu) Co., Ltd.CompletedNon-small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationChina, Korea, Republic of, Singapore, Taiwan
-
Shanghai Chest HospitalUnknownNon-Small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationChina
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
First People's Hospital of HangzhouNot yet recruitingBrain Metastases | EGFR Positive Non-small Cell Lung CancerChina